# Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed

> **NCT07422259** · NA · COMPLETED · sponsor: **Medivis SRL** · enrollment: 40 (actual)

## Conditions studied

- Keratoconjunctivitis Sicca

## Interventions

- **DEVICE:** Reinnerva/Lubristil +G sterile eye drops (artificial tears)
- **DEVICE:** Vismed sterile eye drops (artificial tears)

## Key facts

- **NCT ID:** NCT07422259
- **Lead sponsor:** Medivis SRL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-09
- **Primary completion:** 2025-09-03
- **Final completion:** 2025-09-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422259, "Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07422259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
